FI952718A0 - Uusi menetelmä 16beta-metyylisteroidin ja uusien välituotteiden valmistamiseksi - Google Patents

Uusi menetelmä 16beta-metyylisteroidin ja uusien välituotteiden valmistamiseksi

Info

Publication number
FI952718A0
FI952718A0 FI952718A FI952718A FI952718A0 FI 952718 A0 FI952718 A0 FI 952718A0 FI 952718 A FI952718 A FI 952718A FI 952718 A FI952718 A FI 952718A FI 952718 A0 FI952718 A0 FI 952718A0
Authority
FI
Finland
Prior art keywords
give
new
alpha
methyl
16beta
Prior art date
Application number
FI952718A
Other languages
English (en)
Swedish (sv)
Other versions
FI952718A (fi
FI114397B (fi
Inventor
Catherine Geurts
Michel Vivat
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of FI952718A0 publication Critical patent/FI952718A0/fi
Publication of FI952718A publication Critical patent/FI952718A/fi
Application granted granted Critical
Publication of FI114397B publication Critical patent/FI114397B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16
    • C07J7/0055—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Steroid Compounds (AREA)
FI952718A 1994-06-02 1995-06-02 Menetelmä 16beta-metyylisteroidin ja uusien välituotteiden valmistamiseksi ja menetelmässä käytettävät välituotteet FI114397B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9406743 1994-06-02
FR9406743A FR2720747B1 (fr) 1994-06-02 1994-06-02 Nouveau procédé de préparation d'un stéroïde 16béta-méthyl et nouveaux intermédiaires.

Publications (3)

Publication Number Publication Date
FI952718A0 true FI952718A0 (fi) 1995-06-02
FI952718A FI952718A (fi) 1995-12-03
FI114397B FI114397B (fi) 2004-10-15

Family

ID=9463797

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952718A FI114397B (fi) 1994-06-02 1995-06-02 Menetelmä 16beta-metyylisteroidin ja uusien välituotteiden valmistamiseksi ja menetelmässä käytettävät välituotteet

Country Status (20)

Country Link
US (3) US5596108A (fi)
EP (1) EP0685487B1 (fi)
JP (1) JP3950489B2 (fi)
KR (1) KR100369766B1 (fi)
CN (3) CN1057303C (fi)
AT (1) ATE157669T1 (fi)
AU (1) AU689564B2 (fi)
CA (1) CA2150738C (fi)
DE (1) DE69500643T2 (fi)
DK (1) DK0685487T3 (fi)
ES (1) ES2106623T3 (fi)
FI (1) FI114397B (fi)
FR (1) FR2720747B1 (fi)
GR (1) GR3024626T3 (fi)
HK (1) HK1098760A1 (fi)
HU (1) HU219490B (fi)
RU (1) RU2151774C1 (fi)
TW (1) TW427997B (fi)
UA (1) UA48107C2 (fi)
ZA (1) ZA954453B (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10014847A1 (de) 2000-03-24 2001-10-04 Gsf Forschungszentrum Umwelt Verfahren und Vorrichtung zum Nachweis von Verbindungen in einem Gasstrom
CN100408025C (zh) * 2006-11-24 2008-08-06 上海医药(集团)有限公司 倍他米松β-11物的自乳化组合物及其制备方法和应用
WO2011019821A2 (en) * 2009-08-13 2011-02-17 Marinus Pharmaceuticals, Inc. METHOD FOR MAKING 3α-HYDROXY, 3β- METHYL-5α-PREGNAN-20-ONE (GANAXOLONE)
CN101851264B (zh) * 2010-03-12 2011-08-10 广西万德药业股份有限公司 一种具有16-β-甲基甾体类药物中间体的制备方法
CN103819495B (zh) * 2014-02-28 2016-08-17 上海新华联制药有限公司 倍他米松中间体的制备方法
CN107286216A (zh) * 2016-03-31 2017-10-24 天津金耀集团有限公司 具有多个烯烃甾体化合物的制备方法
CN105693802B (zh) * 2016-04-12 2017-08-25 湖南新合新生物医药有限公司 16β‑甲基甾族化合物的制备方法
CN106866777B (zh) * 2017-04-12 2019-05-24 杭州弘任医药科技有限公司 苯甲孕酮的制备方法
IT201800009683A1 (it) * 2018-10-22 2020-04-22 Ind Chimica Srl Processo per la preparazione di 3α-idrossi-5α-pregnan-20-one (brexanolone)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2703799A (en) * 1954-05-12 1955-03-08 Searle & Co 9alpha-halo-11-oxo-16alpha, 17alpha-epoxyprogesterones
US2705711A (en) * 1954-09-24 1955-04-05 Searle & Co 9beta, 11beta; 16alpha, 17alpha-bisepoxyprogesterone
GB805497A (en) * 1955-07-13 1958-12-10 Glaxo Lab Ltd Steroid intermediates for the preparation of adreno-cortical hormones
DE1041043B (de) * 1955-07-13 1958-10-16 Nat Res Dev Verfahren zur Herstellung von 17ª‡-Hydroxy-16-halogenallopregnanen
US2951857A (en) * 1956-03-13 1960-09-06 Searle & Co 11-oxygenated 16-halo-17-hydroxy-progesterones
US3219674A (en) * 1959-03-11 1965-11-23 Syntex Corp 15-dehydro-16 methyl steroids and process for the production thereof
US3761498A (en) * 1971-06-05 1973-09-25 Plurichemie Anstalt New process of preparation of steroids
WO1988002753A2 (en) * 1986-10-10 1988-04-21 Gist-Brocades N.V. 9-alpha-hydroxy steroids and process for their preparation
HU198736B (en) * 1986-12-29 1989-11-28 Gyogyszerkutato Intezet Process for producing 16-dehydro-20-oxopregnane derivatives

Also Published As

Publication number Publication date
ZA954453B (en) 1996-05-31
HU9501595D0 (en) 1995-07-28
CN1118351A (zh) 1996-03-13
ES2106623T3 (es) 1997-11-01
US6117994A (en) 2000-09-12
HK1098760A1 (en) 2007-07-27
RU95108877A (ru) 1997-05-10
RU2151774C1 (ru) 2000-06-27
EP0685487A1 (fr) 1995-12-06
CN1220996A (zh) 1999-06-30
FI952718A (fi) 1995-12-03
HUT71801A (en) 1996-02-28
US5795982A (en) 1998-08-18
TW427997B (en) 2001-04-01
KR960000915A (ko) 1996-01-25
JPH08169897A (ja) 1996-07-02
DE69500643D1 (de) 1997-10-09
GR3024626T3 (en) 1997-12-31
FI114397B (fi) 2004-10-15
EP0685487B1 (fr) 1997-09-03
US5596108A (en) 1997-01-21
ATE157669T1 (de) 1997-09-15
CN1252081C (zh) 2006-04-19
CN1057303C (zh) 2000-10-11
AU689564B2 (en) 1998-04-02
CA2150738A1 (fr) 1995-12-03
FR2720747A1 (fr) 1995-12-08
UA48107C2 (uk) 2002-08-15
CN1821263A (zh) 2006-08-23
CN100379753C (zh) 2008-04-09
DE69500643T2 (de) 1998-01-08
HU219490B (hu) 2001-04-28
DK0685487T3 (da) 1998-04-20
KR100369766B1 (ko) 2003-12-11
CA2150738C (fr) 2006-04-18
AU2044295A (en) 1995-12-14
FR2720747B1 (fr) 1996-07-12
JP3950489B2 (ja) 2007-08-01

Similar Documents

Publication Publication Date Title
HK1098760A1 (en) An intermediate for the preperation of a 16 beta-methyl steroid
KR860005832A (ko) 위치 10에 치환된 스테로이드의 제조방법
GR3018330T3 (en) O-methyl derivatives of azithromycin A, process and intermediates for their preparation, and use thereof in the preparation of pharmaceuticals.
FI880742A (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten, 7-asemassa substituoitujen 19-norsteroidien valmistamiseksi
FI842457A0 (fi) 1-alkyl-androsta-1,4-dien-3,17-dioner, deras framstaellningsfoerfarande och dessa innehaollande farmaceutiska produkter.
ATE136902T1 (de) Neues verfahren zur herstelling von 16-alpha- methyl-steroide
CA2394731A1 (en) Process for preparing 17alpha-acetoxy-11beta-[4-n,n-(dimethylamino)phenyl]-21-methoxy-19-norpregna-4,9-diene-3,20-dione, intermediates useful in the process, and processes for preparing such intermediates
FI913699A0 (fi) Menetelmä farmaseuttisesti käyttökelpoisten 4'-epi-4'-aminoantrasykliinien valmistamiseksi sekä menetelmässä käytettävät välituotteet
FI814127L (fi) Foerfarande foer framstaellning av 11beta 21-dihydroxi-2'metyl-5'betah-1,4-pregnadieno (16,17-d)-oxazol-3,20-dion
NO942925L (no) Fremgangsmåte for fremstilling av 3-karbonylandrostadien-17-karboksamider
ES2064440T3 (es) Cefalosporinas, proceso para su preparacion, intermedios y composiciones farmaceuticas.
DE69101790D1 (de) Verfahren zur Herstellung von Vitamin A Aldehyd.
FR2694007B1 (fr) Nouveau procédé de préparation de composés stéroïdes 20-céto 21 (S) hydroxy et des intermédiaires.
IE780933L (en) Pregnene derivatives
DE59800127D1 (de) 9 Alpha-Hydroxy-8 Alpha-estra-1,3,5(10)-triene und Verfahren zu deren Herstellung
RO95696A2 (ro) Derivati de 1,1-oxibis(4n-benzamido) bnzen si procedeu de preparare al acestora
ATE107363T1 (de) Herstellung von 7-beta-hydroxy-4-pregnen-3,20- dion-derivaten.
JPS5788200A (en) Synthetic intermediate of corticoids
ES8704968A1 (es) Procedimiento para la preparacion de 9alfa-cloro-11beta-hidroxi-16beta-metil-1,4-preguaddien-3,20-diona-17-propionato-21-(-2-hidroxibenzoato).
FR2442857A1 (fr) Nouveau steroide de la serie du pregnane et son procede de preparation
HUT46309A (en) Process for producing 2,6-di/hydroxy-methyl/-pyridine-bis/n-methyl-carbamate/
FR2438055A1 (fr) Nouveaux homo-nor-steroides et leurs methodes de preparation
JPS5625200A (en) Preparation of hydrocortisone derivative

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: HOECHST MARION ROUSSEL

PC Transfer of assignment of patent

Owner name: AVENTIS PHARMA S.A.

FG Patent granted

Ref document number: 114397

Country of ref document: FI

MM Patent lapsed